CLINICAL_TRIALS
trial_result
· 2015-07-20
Clinical Trial Update: Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency [Phase 2, Phase 3]
Summary
A phase 2/3 clinical trial evaluating once-daily oral modified-release hydrocortisone for adrenal insufficiency has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Adrenal Insufficiency | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-07-20